Autonomous Drones & Defense
A defense-tech roll-up scaling revenue fast on a large contracted backlog — funded by heavy share issuance, which is the whole argument.
Personal notes published for reference. Figures are sourced from company filings, releases, and press coverage as of the date above — the interpretation is mine and may be wrong.
The hardest of the four to underwrite here. Management is running an aggressive acquisition strategy — six acquisitions and counting — which demands integration skill on top of operating skill. They have consistently raised guidance, which is a point in their favor, but the track record is short.
Drone warfare and counter-UAS, which has gone from speculative to a procurement priority. Management points to a pipeline of roughly $4.3B across 45+ program submissions, and the $982M Army IDIQ validates relevance to long-term US drone procurement. Modern conflict has made this category structurally larger.
About $1.4–1.5B in cash and short-term investments with minimal debt — genuinely funded. But the company is still posting substantial losses as expenses scale with the business. Management expects EBITDA positivity during 2026; that has not happened yet.
The strongest of the four criteria for this name. 2025 revenue of $50.7M was up 605% YoY. Q2 2026 revenue hit a record $83.8M against a $68.5M consensus, and full-year guidance was raised repeatedly — from $375M to $390M to more than $525M.
The bull case is the order book. Backlog is what turns a story about drone demand into contracted, visible revenue.
$175M of new orders in Q2, plus a further $105M in Q3 to date. Backlog has climbed from roughly $457M earlier in the year to $613M reported, and ~$757M pro forma once the Q3 acquisitions are included.
Five acquisitions totaling $557M completed in 2026 — Mistral, World View Enterprises, Omnisys, then DZYNE and Cyberhawk in Q3 — expected to contribute roughly $230M of 2026 revenue. DZYNE alone adds a stated $1.5B pipeline and ~$111M of backlog.
Collaboration with Palantir on AI-enabled defense systems, and the LADOS command-and-control platform debuting alongside a suite of autonomous defense products.
Gross margins holding near 50% despite the pace of scaling and integration — a genuinely good sign for a company growing this fast through acquisition.
This is the reason the share price hasn't followed the revenue. The growth is real; so is the cost of funding it.
Shares outstanding rose roughly 324% in a single year — diluted average share count around 462M as of March 2026. At the May 2026 annual meeting, shareholders approved raising authorized common stock from 800M to 1.2B shares, with over 50% already issued and nearly 25% reserved for higher-strike warrants. A $229M ESOP-related shelf was filed alongside.
So the company both has diluted heavily and has explicitly created room to keep doing it. That's the bear case in one paragraph.
Revenue growth has outpaced share issuance. On a per-share basis the business is still expanding — and the acquisitions bought with that equity are what produced the backlog. Forward EV/revenue has compressed from ~21x to single digits as estimates caught up. Whether that's cheap or a value trap depends entirely on whether the backlog converts.
Roughly 40–44% of the float has been reported sold short — an unusually crowded bet against the dilution thesis, which makes the stock reflexive in both directions.
Two things: (1) does backlog convert to recognized revenue on schedule, and (2) does share count stabilize now that the cash pile is large. If both happen, the per-share math turns quickly. If issuance continues while conversion slips, the bears are right.
Six acquisitions in roughly a year is a lot of moving parts. Roll-ups fail on integration far more often than on demand.
Q2 adjusted loss of $0.19/share missed the $0.10 consensus. Revenue beats haven't yet translated into the bottom line.
Revenue is heavily tied to defense procurement timing and budget cycles — lumpy by nature, and politically exposed.